pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,552
stories
Jul 8, 26
Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study says
stat
Jul 8, 26
STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
stat
Jul 8, 26
Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal
biopharma dive
Jul 8, 26
Satellos gives early look at Duchenne pill in adults ahead of key data in children
endpoints
Jul 8, 26
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
Jul 7, 26
Vera's IgAN approval kicks off competition with Otsuka
endpoints
Jul 7, 26
STAT+: FDA approves Vera Therapeutics kidney disease treatment
stat
Jul 7, 26
Oberland pours up to $400M into MeiraGTx eye gene therapies
biopharma dive
Jul 7, 26
Compass Pathways touts durability data for psilocybin drug in depression ahead of year-end filing
endpoints
Jul 7, 26
Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials
endpoints
Jul 7, 26
Vertex to acquire Crinetics in $10B foray into endocrine disease drugs
biopharma dive
Jul 7, 26
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
stat
Jul 7, 26
Vera Therapeutics wins FDA nod for closely watched kidney disease drug
biopharma dive
Jul 6, 26
FDA approves 23 new drugs in first half, overcoming staff-cut concerns
endpoints
Jul 6, 26
Bristol Myers details Krazati confirmatory study failure in colorectal cancer
endpoints
Jul 6, 26
Opinion: The smart way to regulate the peptide boom
stat
Jul 2, 26
A PureTech startup banks $180M for a new IPF drug
biopharma dive
Jul 2, 26
Otsuka reports long-term kidney data key to Voyxact's bid for full approval
endpoints
Jul 2, 26
Roche KRAS drug succeeds in head-to-head lung cancer study
biopharma dive
Jul 2, 26
Vertex's sickle cell therapy approved for kids; United Therapeutics buys startup
endpoints
Jul 2, 26
BrightGene looks to the West as obesity shot nears China approval
endpoints
Jul 1, 26
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
fda press
Jul 1, 26
FDA approves Orca Bio’s cell therapy to improve transplant outcomes
endpoints
Jul 1, 26
BridgeBio gets funding for drug launch; United buys into cell therapy
biopharma dive
Jul 1, 26
Abivax shares surge as worries subside over immune drug’s cancer risk
biopharma dive
Jul 1, 26
STAT+: FDA approves Orca Bio’s T cell therapy for blood cancer patients
stat
Jun 30, 26
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
fda press
Jun 30, 26
Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program
biopharma dive
Jun 30, 26
Viridian may have edge over Amgen in eye drug showdown, analysts argue
biopharma dive
Jun 30, 26
Sarepta's FDA decision date; Flare gets Anna Protopapas as CEO
endpoints
← prev
page 42 of 52
next →